教育中心 >> 预读材料
-
Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery DiseaseJOURNAL：J Am Coll Cardiol.
-
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding RiskJOURNAL：Circulation.
-
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed TomographyJOURNAL：J Am Coll Cardiol.
-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationJOURNAL：Arterioscler Thromb Vasc Biol.
-
Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up StudyJOURNAL：J Am Heart Assoc.
-
The Year in Cardiovascular Medicine 2020: Coronary InterventionJOURNAL：Eur Heart J.
-
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus TicagrelorJOURNAL：J Am Coll Cardiol.
-
Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCIJOURNAL：Eurointervention.
-
Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial InfarctionJOURNAL：JACC
-
Restenosis, Stent Thrombosis, and Bleeding Complications - Navigating Between Scylla and CharybdisJOURNAL：J Am Coll Cardiol.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
